Teza Capital Management LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 38,090 shares of the company’s stock, valued at approximately $2,034,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Global Retirement Partners LLC lifted its position in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after buying an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new position in shares of Doximity during the 4th quarter worth approximately $43,000. Finally, Kapitalo Investimentos Ltda bought a new position in shares of Doximity during the 4th quarter worth approximately $50,000. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Stock Performance
Shares of NASDAQ:DOCS opened at $52.60 on Friday. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21. The firm has a fifty day moving average of $57.40 and a 200 day moving average of $57.84. The firm has a market capitalization of $9.82 billion, a PE ratio of 52.60, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.
Analyst Upgrades and Downgrades
DOCS has been the topic of a number of research reports. Raymond James lowered their price target on shares of Doximity from $83.00 to $65.00 and set an “outperform” rating on the stock in a report on Friday. Needham & Company LLC lowered their target price on shares of Doximity from $82.00 to $67.00 and set a “buy” rating on the stock in a report on Friday. Canaccord Genuity Group lowered their target price on shares of Doximity from $71.00 to $50.00 and set a “hold” rating on the stock in a report on Friday. The Goldman Sachs Group boosted their target price on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Finally, Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and an average target price of $61.78.
Get Our Latest Research Report on Doximity
Insider Buying and Selling at Doximity
In other Doximity news, CFO Anna Bryson sold 45,000 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at $20,440,552.95. This represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares of the company’s stock, valued at approximately $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 37.40% of the company’s stock.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Five stocks we like better than Doximity
- Short Selling – The Pros and Cons
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Savvy Investors Are Raising a Glass for Heineken Stock
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.